NasdaqGM:ADMABiotechs
Assessing ADMA Biologics (ADMA) Valuation After Recent Share Price Rebound
Event context and recent share performance
ADMA Biologics (ADMA) has come onto many investors’ radar after a 3.2% gain over the past day, contrasting with a 7% decline over the past month and a 10% drop year to date.
See our latest analysis for ADMA Biologics.
The recent 1 day share price return of 3.21% comes against a weaker year to date share price return of 10.01% and a modest 1 year total shareholder return of 1.2%. This suggests that shorter term momentum is trying to pick up after a...